Oct. 26 Quick Takes: COVID trips up Spectrum’s Rolontis at FDA; plus Jazz-SpringWorks, Novartis’ iptacopan, Kantaro, Eternygen

By KAREN TKACH TUZMAN AND PAUL BONANOS, ASSOCIATE EDITORS

Delay for Spectrum due to COVID-19 travel restrictions
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) said